Investors

A pharmaceutical drug developer with a strong investment case

Presentations

Company investor and analyst presentation – acquisition of RTT

October 5, 2020

Acquisition of Rare Thyroid Therapeutics – Interview at Redeye

October 5, 2020

PledPharma and RTT agree to join forces

October 5, 2020

Pareto Healthcare Seminar – Company presentation

September 2, 2020

Pareto Helthcare Seminar – interview with PledPharma’s CEO

September 2, 2020

Interview with PledPharma’s CEO at Redeye

August 20, 2020

Company presentation, June 2020

June 11, 2020

Interview with PledPharma’s CEO at Penser

4 juni, 2020

The Penser Corporate Day

June 4, 2020

Redeye Growth Day

June 2, 2020

ABGSC Life Science Summit

May 26, 2020

Pareto interview with PledPharma’s CEO

April 23, 2020

Presentation AGM 2020

April 23, 2020

Webcast concerning the POLAR program

April 6, 2020

Telephone conference – PledPharma provides update on the clinical POLAR program

March 2. 2020

Redeye Interview with PledPharma’s CEO

February 18, 2020

Telephone conference – PledPharma provides update on the clinical POLAR program, clinical hold in the US

January 23, 2020

Company presentation, January 2020

January 10, 2020

Redeye Interview with PledPharma’s CEO

December, 2019

Aktiespararnas Healthcare direkt (in Swedish):
Pledpharmas vd om Pledox förutsättningar i fas 3-studien POLAR samt marknadspotentialen

November 14, 2019

Company presentation, November 2019

November 7, 2019

Interview with PledPharma’s CEO about the third quarter

October 23, 2019

Web cast CMD

Capital Markets Day – presentation

Mar 26, 2019

Calendar and upcoming reports

November 11, 2020
Interim report third quarter 2020

October 28, 2020
Extrodinary general meeting

Show more events

Share

Twitter
LinkedIn

Contact us

Address: Grev Turegatan 11 C, 114 46 Stockholm, Sweden

Phone: +46 8 679 72 10

E-mail: info@pledpharma.com